Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Universal low-dose iron supplementation for pregnant women recommended by CDC.

This article was originally published in The Tan Sheet

Executive Summary

UNIVERSAL IRON SUPPLEMENTATION DURING PREGNANCY RECOMMENDED BY CDC in a report issued in the April 3 Morbidity & Mortality Weekly Report. The Centers for Disease Control & Prevention analysis, "Recommendations to Prevent and Control Iron Deficiency" in the U.S., recommends for primary prevention of iron deficiency during pregnancy that all women "start oral, low-dose (30 mg/day) supplements of iron at the first prenatal visit," be encouraged to "eat iron-rich foods and foods that enhance iron absorption" and follow low-iron diets "in optimizing their dietary iron intake." For secondary prevention, CDC recommends that women be screened for anemia at their first prenatal care visit, "using anemia criteria for the specific stage of pregnancy."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088300

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel